Loading clinical trials...
Loading clinical trials...
A Clinical and Pharmacologic Study of the Combination of Erlotinib and Bexarotene in Resectable Clinical Stage I-II Non-Small Cell Lung Cancer
Conditions
Interventions
erlotinib (Tarceva) and bexarotene (Targretin)
Locations
1
United States
Norris Cotton Cancer Center
Lebanon, New Hampshire, United States
Start Date
December 1, 2005
Primary Completion Date
August 1, 2010
Completion Date
August 1, 2010
Last Updated
January 8, 2019
NCT06667908
NCT04165798
NCT06875310
NCT07046923
NCT07222566
NCT06667076
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions